Cian Healthcare has published the postal ballot notice in newspapers, seeking shareholder approval for material related party transactions and the appointment of a Managing Director and a Woman Non-Executive Director. The remote e-voting process opens on June 10, 2026, and closes on July 9, 2026, with a record date of June 5, 2026, to determine shareholder eligibility.

The resolutions seek approval for transactions with promoters, including Mr. Pradeep Kumar Jain, Mr. Rajesh Jain, and Ananta Medicare Limited. These transactions involve unsecured loans, interest payments, and resource sharing arrangements. The estimated aggregate value of these transactions for the financial year 2026-27 is approximately ₹114.56 crore, exceeding the materiality threshold of ₹2.94 crore.

Shareholders are also asked to approve special resolutions to enhance the company’s borrowing limits and authorize the Board to dispose of the whole or substantially the whole of the undertaking. The proposed borrowing limit is capped at ₹100 crore. Additionally, the notice seeks approval for loans, guarantees, and securities under Sections 185 and 186 of the Companies Act, 2013, also up to an aggregate limit of ₹100 crore.

The postal ballot includes the appointment of Mr. Rajesh Jain as Managing Director for a term of three years from March 16, 2026, to March 15, 2029, and Ms. Simmi Soni as Woman Non-Executive Director. The Board has appointed Mrs. Divya Rani of M/s. Divya Rani & Associates as the Scrutinizer for the e-voting process.

Key Resolutions for Approval

E-Voting Schedule

cian healthcare has scheduled a meeting of its Board of Directors on Saturday, May 30, 2026, to consider and approve the audited financial results for the financial year and half year ended March 31, 2026. The meeting will cover both standalone and consolidated financial statements. This disclosure is significant for shareholders as it will provide a comprehensive view of the company's performance for FY26.

The intimation was made pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that the results will be submitted in XBRL mode as required by the exchange regulations.

In conjunction with the board meeting, the company has implemented a trading window closure. Effective from April 01, 2026, the trading window for dealing in the securities of the company remains closed for all designated persons and their immediate relatives. This restriction is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code.

The trading window will remain closed until 48 hours after the declaration of the audited financial results. This measure is intended to prevent insider trading and ensure market integrity during the period of price-sensitive information disclosure.

Rachit Malhotra, Company Secretary and Chief Compliance Officer, signed the intimation on May 26, 2026, confirming the schedule and the compliance measures in place.